2003Zhōnghuá yàoxué zázhìRequires access

Studies on the bioequivalence of domestic terazosin tablet in healthy volunteers

Jun Chen

Open publisher page 1 citations

Abstract

OBJECTIVE To observe the bioavailability of domestic terazosin tablet and imported tablet.METHODS A single oral dose of 2 mg domestic or imported terazosin tablet was given to 20 healthy volunteers in a randomized crossover study.Terazosin concentrations in plasma were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as follow: t max (1.08±0.54) and (1.18±0.37) h, c max (44.44±11.72) and (41.28±9.77) μg·L -1 ,MRT (9.48±0.76) and (9.36± 0.90 ) h, t 1/2 (10.10±1.45) and (9.77±1.76) h,AUC 0~36 h (372.82±97.44) and (361.57±83.21) μg·h·L -1 respectively.The relative bioavailability of domestic to imported tablets was (103±13)%.CONCLUSION There was no significant difference between the parameters of two products ( P 0.5).The results demonstrated that the two preparations were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To observe the bioavailability of domestic terazosin tablet and imported tablet.METHODS A single oral dose of 2 mg domestic or imported terazosin tablet was given to 20 healthy volunteers in a randomized crossover study.Terazosin concentrations in plasma were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as follow: t max (1.08±0.54) and (1.18±0.37) h, c max (44.44±11.72) and (41.28±9.77) μg·L -1 ,MRT (9.48±0.76) and (9.36± 0.90 ) h, t 1/2 (10.10±1.45) and (9.77±1.76) h,AUC 0~36 h (372.82±97.44) and (361.57±83.21) μg·h·L -1 respectively.The relative bioavailability of domestic to imported tablets was (103±13)%.CONCLUSION There was no significant difference between the parameters of two products ( P 0.5).The results demonstrated that the two preparations were bioequivalent.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To observe the bioavailability of domestic terazosin tablet and imported tablet.METHODS A single oral dose of 2 mg domestic or imported terazosin tablet was given to 20 healthy volunteers in a randomized crossover study.Terazosin concentrations in plasma were determined by HPLC method.RESULTS The main pharmacokinetics of the two products were as follow: t max (1.08±0.54) and (1.18±0.37) h, c max (44.44±11.72) and (41.28±9.77) μg·L -1 ,MRT (9.48±0.76) and (9.36± 0.90 ) h, t 1/2 (10.10±1.45) and (9.77±1.76) h,AUC 0~36 h (372.82±97.44) and (361.57±83.21) μg·h·L -1 respectively.The relative bioavailability of domestic to imported tablets was (103±13)%.CONCLUSION There was no significant difference between the parameters of two products ( P 0.5).The results demonstrated that the two preparations were bioequivalent.

Key concepts: Bioequivalence, Bioavailability, Terazosin, Crossover study, Pharmacokinetics, Pharmacology, Significant difference, Plasma concentration

Related papers

Back to paper searchBrowse research topicsOriginal source
Studies on the bioequivalence of domestic terazosin tablet in healthy volunteers — Research Paper | ScholarLens